EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Frailty verschlimmert die Behinderung bei progredienter Multipler Sklerose

Taylor R Wicks iD, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock-Guttman, Alexander Burnham, Niels Bergsland iD, Michael G Dwyer iD, Alan T Remaley, Robert Zivadinov iD, Murali Ramanathan iD

Annals of Clinical and Translational Neurology · 2026-04 · 13 (4) · 654-664

DOI: 10.1002/acn3.70243 ↗

Auf einen Blick

In einer multizentrischen Querschnittsstudie war Frailty bei schwerer progredienter MS mit stärkerer Behinderung verbunden. Die late severe PMS-Gruppe hatte höhere EDSS- und Frailty-Werte als die Kontrollgruppe.

Fragestellung

Frailty bei schwerer progredienter Multipler Sklerose erfassen und die zugrunde liegenden Mechanismen untersuchen.

Methode

Prospektive, querschnittliche multizentrische Studie mit 53 Patient:innen in der late severe PMS-Gruppe und 53 in der Kontrollgruppe; neurologische und MRT-Untersuchungen sowie Blutproben; Frailty nach Edmonton Frail Scale.

Ergebnisse

Die late severe PMS-Gruppe hatte eine höhere mediane EDSS (8.0 vs. 6.0, p < 0.001), höhere Frailty-Prävalenz (73.1% vs. 23.1%, p < 0.001) und höhere Frailty-Scores (8.87 vs. 5.52, p < 0.001).

Schlussfolgerung der Autor:innen

Frailty ist positiv mit der MS-Behinderung assoziiert. Inflammatorische und metabolische Vulnerabilität sind bei PMS mit Frailty verbunden.

Kernaussagen

  • Frailty war bei schwerer progredienter MS häufiger als in der Kontrollgruppe.
  • Positive Frailty war mit höherem EDSS assoziiert.
  • IVX und MVX waren in den Kontrollen mit Frailty verbunden.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 14.11.2025. Verfasst von Taylor R Wicks und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Frailty, Multiple Sclerosis, Chronic Progressive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Annette Funicello Research Fund for Neurological Diseases, Jacquemin Family Foundation, Department of Defense Congressionally Directed Medical Research Programs.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms.

Methods

This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing ( n = 53) and an age, sex, and disease duration‐matched control PMS group ( n = 53). Participants received neurological and MRI assessments and provided blood samples. Frailty was measured on the Edmonton Frail Scale. Disability was measured on the Expanded Disability Status Scale (EDSS), and fatigue was assessed on the Fatigue Severity Scale. The inflammatory vulnerability index (IVX) and metabolic vulnerability index (MVX) were computed from nuclear magnetic resonance spectroscopy‐derived metabolomic profiling. Serum neurofilament (sNfL), glial fibrillary acidic protein (GFAP), and growth differentiation factor 15 (GDF15) levels were obtained.

Results

The late severe PMS group had a higher median EDSS (8.0 vs. 6.0, p < 0.001) than the matched control PMS group. The late severe PMS group had a higher prevalence of frailty (73.1% vs. 23.1%, p < 0.001) and higher frailty scores (8.87 vs. 5.52, p < 0.001) than the control PMS group. EFS was associated with EDSS in both PMS groups. Positive frailty status was associated with a 1.19‐point greater EDSS ( p = 0.012) in the control PMS group and a 0.436‐point greater EDSS in the late severe PMS group ( p = 0.002). In PMS controls, the EFS and frailty status were associated with IVX ( p = 0.044 for EFS) and MVX ( p = 0.036 for EFS).

Conclusions

Frailty is positively associated with MS disability. Inflammatory and metabolic vulnerability are associated with frailty in PMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyMultiple Sclerosis, Chronic ProgressiveHumansMaleFemaleCross-Sectional StudiesMiddle AgedAgedProspective StudiesSeverity of Illness IndexDisability EvaluationFatigueDisease Progression

Stichwörter der Autor:innen

agingfrailtymetabolic dysfunctionprimary progressive multiple sclerosissecondary progressive multiple sclerosis

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.
  • Lipoprotein Metabolism Laboratory, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Jacobs Multiple Sclerosis Center, University at Buffalo, The State University of New York, Buffalo, New York, USA.
  • Department of Imaging Sciences, Strong Memorial Hospital, University of Rochester, Rochester, New York, USA.
  • The Boston Home, Dorchester, Massachusetts, USA.
  • Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.

ORCID-Profile: Taylor R Wicks, Niels Bergsland, Michael G Dwyer, Robert Zivadinov, Murali Ramanathan

Förderung

  • Annette Funicello Research Fund for Neurological Diseases
  • Jacquemin Family Foundation
  • Department of Defense Congressionally Directed Medical Research Programs
  • Congressionally Directed Medical Research Programs

Zitieren

APA

Wicks, T. R., Wolska, A., Ghazal, D., Jakimovski, D., Weinstock-Guttman, B., Burnham, A., Bergsland, N., Dwyer, M. G., Remaley, A. T., Zivadinov, R., & Ramanathan, M. (2026). Frailty Exacerbates Disability in Progressive Multiple Sclerosis. Annals of Clinical and Translational Neurology, 13(4), 654-664. https://doi.org/10.1002/acn3.70243

Vancouver

Wicks TR, Wolska A, Ghazal D, Jakimovski D, Weinstock-Guttman B, Burnham A, et al. Frailty Exacerbates Disability in Progressive Multiple Sclerosis. Annals of Clinical and Translational Neurology. 2026;13(4):654-664. doi:10.1002/acn3.70243

BibTeX
@article{Wicks2026,
  author = {Wicks, Taylor R and Wolska, Anna and Ghazal, Diala and Jakimovski, Dejan and Weinstock-Guttman, Bianca and Burnham, Alexander and Bergsland, Niels and Dwyer, Michael G and Remaley, Alan T and Zivadinov, Robert and Ramanathan, Murali},
  title = {Frailty Exacerbates Disability in Progressive Multiple Sclerosis},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  volume = {13},
  number = {4},
  pages = {654--664},
  doi = {10.1002/acn3.70243}
}
Kostenlos starten →